Release notes for Online Service Request
MedCAD is proud to officially announce FDA 510(k) market clearance for AccuPlate® Patient-Specific Plates for mandibular reconstructive surgery.
DALLAS, TX, June 1, 2021 – MedCAD is proud to announce an exclusive agreement with Premier, Inc. (NASDAQ: PINC) to provide point-of-care solutions through 3D medical printing and surgical planning.
The culmination of years of research and development, long hours, a relentless obsession with customer service and new market clearances has earned MedCAD a brand refresh that drives forward our mission of Restoring Humanity One Patient at a Time.
MedCAD is proud to announce 510(k) market clearance for its new AccuPlan System through the Food and Drug Administration (FDA).
Physicians and suppliers are excited because as of July 1, 2019, the American Medical Association (AMA) is using provisional CPT® Codes corresponding to Surgical Planning, Guides, 3D Anatomical Models, and corresponding products and services.